Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ömer Ekin"'
Publikováno v:
2022 IEEE 13th International Symposium on Power Electronics for Distributed Generation Systems (PEDG).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3b2a0772be8f4578ed2e3d129e6a1ed
https://doi.org/10.1109/pedg54999.2022.9923074
https://doi.org/10.1109/pedg54999.2022.9923074
Autor:
Tahir Darcın, Istemi Serın, Mehmet Can Ugur, Omer Ekinci, İpek Yönal Hindilerden, Seval Akpınar, Tuba Hacıbekiroglu, Sinan Demircioğlu, Emine Gulturk, Murat Albayrak, İsmet Aydoğdu, Mehmet Sinan Dal, Mehmet Hilmi Doğu, Sinem Namdaroğlu, Ali Dogan, Meliha Nalçacı, Burhan Turgut, Semih Başcı, Fevzi Altuntaş
Publikováno v:
Hitit Medical Journal, Vol 6, Iss 2, Pp 186-192 (2024)
Objective: We present data of patients with relapsed/ refractory T cell lymphomas treated with brentuximab vedotin (BV) in real-world practice. Material and Method: This study is an observational, multi-center, retrospective study. The data of patien
Externí odkaz:
https://doaj.org/article/9ca01e30518240fc9f0619b73350c36a
Autor:
Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Ayse Uysal, Figen Atalay, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Birgul Onec, Hakan Keski, Mufide Okay Ozgeyik, Sebnem Izmir Guner, Esra Terzi Demirsoy, Oktay Bilgir, Birol Guvenc
Publikováno v:
Medicina, Vol 60, Iss 10, p 1623 (2024)
Background and Objectives: Acute myeloid leukemia and myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS are both limited in number and efficacy. This study aims to eva
Externí odkaz:
https://doaj.org/article/3bac2331ab0843e7ac42188b71925530
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Autor:
Ali Dogan, Omer Ekıncı, Narin Yıldırım Dogan, Sinan Demırcıoglu, Cengiz Demır, Cihan Ural, Ramazan Esen
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S41-S42 (2023)
Objective: Hemolytic anemia defines a group of anemias occurring due to the shortening of normal red blood cell (RBC) lifespan due to factors extrinsic to RBCs or structural changes in RBCs. As a result of the increase in RBC hemolysis, anemia and as
Externí odkaz:
https://doaj.org/article/9f2001ede9404520b8308c0ff17de0e8
Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia
Publikováno v:
Bezmiâlem Science, Vol 10, Iss 4, Pp 402-408 (2022)
Objective:Chromosomal abnormalities are one of the most important prognostic factors in acute myeloid leukemia (AML). However, not all patients may have such informative chromosomal abnormalities. Although there are many studies on the prognostic val
Externí odkaz:
https://doaj.org/article/6216e4967c524ad7bc6db8917f8320da
Autor:
Hakan Çelik, Nilgün Yersal, Petek Korkusuz, Ozan Bitik, Ömer Ekin, Ali Aliyev, Gökhan Tunçbilek
Publikováno v:
Journal of Reconstructive Microsurgery. 34:e1-e1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f341979b55a5f3310cb985a839cf683
https://doi.org/10.1055/s-0038-1646944
https://doi.org/10.1055/s-0038-1646944
Autor:
Eren Gündüz, Hakkı Onur Kırkızlar, Elif Gülsüm Ümit, Sedanur Karaman Gülsaran, Vildan Özkocaman, Fahir Özkalemkaş, Ömer Candar, Tugrul Elverdi, Selin Küçükyurt, Semra Paydaş, Özcan Çeneli, Sema Karakuş, Senem Maral, Ömer Ekinci, Yıldız İpek, Cem Kis, Zeynep Tuğba Güven, Aydan Akdeniz, Tiraje Celkan, Ayşe Hilal Eroğlu Küçükdiler, Gülsüm Akgün Çağlıyan, Ceyda Özçelik Şengöz, Ayşe Karataş, Tuba Bulduk, Alper Özcan, Fatma Burcu Belen Apak, Aylin Canbolat, İbrahim Kartal, Hale Ören, Ersin Töret, Gül Nihal Özdemir, Şule Mine Bakanay Öztürk
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 2, Pp 130-135 (2022)
Objective: Castleman disease (CD) is a rare disease also known as angiofollicular lymph node hyperplasia. The two main histological subtypes are the hyaline vascular and plasma cell variants. It is further classified as unicentric CD (UCD) or multice
Externí odkaz:
https://doaj.org/article/90602ce9f9bf437588736f9a063da92f
Autor:
İbrahim Halil Açar, Sebnem Izmir Güner, Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk, Figen Atalay, Gulden Sincan, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk, Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Objectives: Patients with hematologic malignancies have a high risk of coronavirus disease 2019 (COVID-19) mortality. This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematologic malignancies and to d
Externí odkaz:
https://doaj.org/article/84dd9a8b2377465180f49123c3042ffc
Autor:
Ömer Ekinci, Senar Ebinç
Publikováno v:
Van Tıp Dergisi, Vol 27, Iss 3, Pp 287-291 (2020)
INTRODUCTION: We aimed to present the pregnant patients who were consulted with hematologists for microangiopathic hemolytic anemia and/or thrombocytopenia and were diagnosed HELLP syndrome. METHODS: A total of 32 patients, who were diagnosed with HE
Externí odkaz:
https://doaj.org/article/ec26d0d44eef4015a1ef7ba35b14d95d